Dean Vayser
Podiatrist · Carlsbad, CANPI 1013961598
Payments from drug & device makers
Across 188 payments — averaging $6455.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acera Surgical, Inc.$540K
- Organogenesis Inc.$288K
- Biotissue Holdings Inc.$138K
- Endo Pharmaceuticals Inc.$123K
- Lexicon Pharmaceuticals, Inc.$55K
- Averitas Pharma Inc.$23K
- plus $47K from 17 others
Across 27 payments — averaging $8977.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Polarityte, Inc.$147K
- Integra Lifesciences Corporation$94K
- Lexicon Pharmaceuticals, Inc.$2K
What the payments were for
- Consulting fees$17,82576%
- Travel & lodging$2,84012%
- Food & beverage$2,86512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acera Surgical, Inc. | 46 | $539,556 |
| Organogenesis Inc. | 32 | $287,580 |
| Biotissue Holdings Inc. | 5 | $137,719 |
| Endo Pharmaceuticals Inc. | 23 | $123,337 |
| Lexicon Pharmaceuticals, Inc. | 15 | $55,398 |
| Averitas Pharma Inc. | 16 | $23,454 |
| Hartmann USA, Inc. | 6 | $17,612 |
| GRT US Holding, Inc. | 5 | $15,282 |
| Polynovo North America LLC | 3 | $7,986 |
| Convatec Inc. | 12 | $2,646 |
| Alcon Research LLC | 2 | $1,552 |
| KCI USA, Inc. | 4 | $595 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $256 |
| Integra Lifesciences Corporation | 7 | $239 |
| Solventum Corporation | 1 | $150 |
| Sanofi | 1 | $120 |
| Zimmer Biomet | 1 | $117 |
| Misonix Inc | 3 | $57 |
| Acell, Inc. | 1 | $16 |
| Arthrosurface Incorporated | 1 | $15 |
| DJO, LLC | 1 | $14 |
| Medline Industries LP | 1 | $12 |
| Aroa Biosurgery Incorporated | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zetuvit Plus$17,500
- InnovaMatrix AC$1,866
- Prokera$464
- AmnioGraft$464
- AmnioGuard$464
- CONVATEC INC.$325
- Apligraf$324
- Restrata Wound Matrix$276
- PREVENA$150
- LIBTAYO$120
- Bone Healing Product Portfolio$117
- AQUACEL AG$112
How this compares
$1,213,720 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 16 | $4,278 |
| Doxycycline Hyclate | 17 | $149 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Carlsbad
- Fardin HakakianTarzana$2.8M
- David GuzmanNapa$2.1M
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.6M
- David ArmstrongLos Angeles$1.4M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- Shawn CazzellFresno$788K
- Philip WrotslavskyPoway$269K
- Stanley MathisLos Angeles$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.